Changing epidemiology of candidaemia in Australia
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Objectives: Knowledge of contemporary epidemiology of candidaemia is essential. We aimed to identify changes since 2004 in incidence, species epidemiology and antifungal susceptibilities of Candida spp. causing candidaemia in Australia. Methods: These data were collected from nationwide active laboratory-based surveillance for candidaemia over 1 year (within 2014-2015). Isolate identification was by MALDI-TOF MS supplemented by DNA sequencing. Antifungal susceptibility testing was performed using Sensititre YeastOne™. Results: A total of 527 candidaemia episodes (yielding 548 isolates) were evaluable. The mean annual incidence was 2.41/105 population. The median patient age was 63 years (56% of cases occurred in males). Of 498 isolates with confirmed species identity, Candida albicans was the most common (44.4%) followed by Candida glabrata complex (26.7%) and Candida parapsilosis complex (16.5%). Uncommon Candida species comprised 25 (5%) isolates. Overall, C. albicans (>99%) and C. parapsilosis (98.8%) were fluconazole susceptible. However, 16.7% (4 of 24) of Candida tropicalis were fluconazole- and voriconazole-resistant and were non-WT to posaconazole. Of C. glabrata isolates, 6.8% were resistant/non-WT to azoles; only one isolate was classed as resistant to caspofungin (MIC of 0.5 mg/L) by CLSI criteria, but was micafungin and anidulafungin susceptible. There was no azole/echinocandin co-resistance. Conclusions: We report an almost 1.7-fold proportional increase in C. glabrata candidaemia (26.7% versus 16% in 2004) in Australia. Antifungal resistance was generally uncommon, but azole resistance (16.7% of isolates) amongst C. tropicalis may be emerging.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While the proportion of C. albicans was 70–80% in the 1980–1990s,54 it has now declined to 40–60% in most geographic areas.25,55,56”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [55]
In the citing paper
“Independent of these geographic variations, there has been a clear worldwide trend of decreasing proportions of C. albicans as the causative pathogen.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [55]
Citations
Cites
Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics
White, T. J., Bruns, T., Lee, S., & Taylor, J. (1990) · PCR Protocols · doi:10.1016/b978-0-12-372180-8.50042-1 · Cited by 36,648
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
White, T. C., Bruns, T. D., Lee, S., Taylor, F. J. R., White, T., Lee, S., Taylor, D. L., & Shawe‐Taylor, J. (1990) · Cited by 2,604
Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793
Incidence, characteristics and outcome of ICU-acquired candidemia in India
Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Kaur, H., Capoor, M., Chhina, D., Rao, R., Eshwara, V. K., Xess, I., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3603-2 · Cited by 454
Self-citationPfaller, M. A., & Diekema, D. J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.t01-1-00844.x · Cited by 423
Pfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101510 · Cited by 396
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
Research works printed but not linked: 1
- Clinical and Laboratory Standards Institute. Epidemiological Cutoff Values for Antifungal Susceptibility Testing—First Edition: Approved Standard M59 . CLSI, Wayne, PA, USA, 2016.
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825
Changes in the epidemiological landscape of invasive candidiasis
Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx444 · Cited by 547
Antifungal Susceptibility Testing: Current Approaches
Berkow, E. L., Lockhart, S. R., & Ostrosky-Zeichner, L. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-19 · Cited by 368
Candida parapsilosis: from genes to the bedside
Tóth, R., Nosek, J., Mora-Montes, H. M., Gabaldon, T., Bliss, J. M., Nosanchuk, J. D., Turner, S. A., Butler, G., Vágvölgyi, C., & Gácser, A. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-18 · Cited by 327
“5% of Candida bloodstream infections (44).”
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Arastehfar, A., Gabaldón, T., Garcia-Rubio, R., Jenks, J. D., Hoenigl, M., Salzer, H. J. F., Ilkit, M., Lass-Flörl, C., & Perlin, D. S. (2020) · Antibiotics · doi:10.3390/antibiotics9120877 · Cited by 292
Risk factors for candidemia: a prospective matched case-control study
FUNGINOS, T., Poissy, J., Groups, A. F. S., Damonti, L., Bignon, A., Khanna, N., Von Kietzell, M., Boggian, K., Neofytos, D., Vuotto, F., et al. (2020) · Critical Care · doi:10.1186/s13054-020-2766-1 · Cited by 188
Emerging multidrug-resistant Candida species
Colombo, A. L., Júnior, J. N. D. A., & Guinea, J. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000411 · Cited by 177
A New Age in Molecular Diagnostics for Invasive Fungal Disease: Are We Ready?
Kidd, S. E., Chen, S. C.-A., Meyer, W., & Halliday, C. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02903 · Cited by 166
Self-citationBranco, J., Miranda, I. M., & Rodrigues, A. G. (2023) · Journal of Fungi · doi:10.3390/jof9010080 · Cited by 164
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S. (2020) · Journal of Fungi · doi:10.3390/jof6030138 · Cited by 145
Astvad, K. M. T., Johansen, H. K., Røder, B. L., Rosenvinge, F. S., Knudsen, J. D., Lemming, L., Schønheyder, H. C., Hare, R. K., Kristensen, L., Nielsen, L., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01564-17 · Cited by 125
Quindós, G., Marcos‐Arias, C., San-Millán, R., Mateo, E., & Eraso, E. (2018) · International Microbiology · doi:10.1007/s10123-018-0014-1 · Cited by 131
Mechanisms of Pathogenic Candida Species to Evade the Host Complement Attack
Singh, D. K., Tóth, R., & Gácser, A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00094 · Cited by 119
Xiao, M., Chen, S. C.-A., Kong, F., Xu, X.-L., Yan, L., Kong, H.-S., Fan, X., Hou, X., Cheng, J.-W., Zhou, M.-L., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz573 · Cited by 115
Self-citationInvasive candidiasis species distribution and trends, United States, 2009-2017
Ricotta, E. E., Lai, Y. L., Babiker, A., Strich, J. R., Kadri, S. S., Lionakis, M. S., Prevots, D. R., & Adjemian, J. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa502 · Cited by 114
Castanheira, M., Deshpande, L. M., Messer, S. A., Rhomberg, P. R., & Pfaller, M. A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.09.003 · Cited by 105
Epidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
“25,40,41,55,61 Comparatively, the proportion of C. parapsilosis has increased in Asia (including Japan and China), Latin America (including Brazil) and Southern Europe, 31,62–65 and the proportion of C. tropicalis has increased particularly in Latin America, and large parts of Asia.”
BackgroundInfluentialNishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102
Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Kaur, H., & Chakrabarti, A. (2017) · Journal of Fungi · doi:10.3390/jof3030041 · Cited by 93
“reported implementation of aggressive hand hygiene practices in addition to fluconazole prophylaxis to be more successful in preventing candidemia in preterm infants of <33 weeks in NICU than prophylaxis alone [13].”
BackgroundBilal, H., Shafiq, M., Hou, B., Islam, R., Khan, M. N., Khan, R. U., & Zeng, Y. (2022) · Virulence · doi:10.1080/21505594.2022.2123325 · Cited by 91
Teh, B. W., Yeoh, D. K., Haeusler, G. M., Yannakou, C. K., Fleming, S. A., Lindsay, J., & Slavin, M. A. (2021) · Internal Medicine Journal · doi:10.1111/imj.15588 · Cited by 95
Self-citationFarmakiotis, D., & Kontoyiannis, D. P. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.019 · Cited by 83
Canela, H. M. S., Cardoso, B., Vitali, L. H., Coêlho, H. C., Martínez, R., & Ferreira, M. E. D. S. (2017) · Mycoses · doi:10.1111/myc.12695 · Cited by 94
Bartlett, A. W., Cann, M. P., Yeoh, D. K., Bernard, A., Ryan, A. L., Blyth, C. C., Kotecha, R. S., McMullan, B. J., Moore, A. S., Haeusler, G. M., et al. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27564 · Cited by 70
Self-citationKeighley, C., Cooley, L., Morris, A. J., Ritchie, D., Clark, J. E., Boan, P., & Worth, L. J. (2021) · Internal Medicine Journal · doi:10.1111/imj.15589 · Cited by 73
Self-citationKhan, Z., Ahmad, S., Al-Sweih, N., Mokaddas, E., Al-Banwan, K., Alfouzan, W., Al-Obaid, I., Al-Obaid, K., Asadzadeh, M., Jeragh, A., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216250 · Cited by 65
Jia, X., Li, C., Cao, J., Wu, X., & Zhang, L. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3304-9 · Cited by 66
Gupta, P., Gupta, S., Sharma, M., Kumar, N., Pruthi, V., & Poluri, K. M. (2018) · ACS Omega · doi:10.1021/acsomega.8b01856 · Cited by 68
Pfaller, M. A., Rhomberg, P. R., Wiederhold, N. P., Gibas, C. F. C., Sanders, C. J., Fan, H., Mele, J., Kovanda, L. L., & Castanheira, M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01230-18 · Cited by 68
Al-Dorzi, H. M., Sakkijha, H., Khan, R., Aldabbagh, T., Toledo, A., Ntinika, P., Al Johani, S. M., & Arabi, Y. M. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066618767835 · Cited by 61
Ding, L., Xia, R., Zhang, Q., Bai, C., Li, Z., & Zhang, P. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2636-x · Cited by 67
Beardsley, J., Kim, H. Y., Dao, A., Kidd, S. E., Alastruey‐Izquierdo, A., Sorrell, T. C., Tacconelli, E., Chakrabarti, A., Harrison, T. S., Bongomin, F., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae041 · Cited by 61
Self-citationJin, L., Cao, Z., Wang, Q., Wang, Y., Wang, X., Chen, H., & Wang, H. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3082-0 · Cited by 56
Arastehfar, A., Daneshnia, F., Zomorodian, K., Najafzadeh, M. J., Khodavaisy, S., Zarrinfar, H., Hagen, F., Zare Shahrabadi, Z., Lackner, M., Mirhendi, H., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02503-18 · Cited by 54
Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox
Kane, A., & Carter, D. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040482 · Cited by 58
Keighley, C., Kim, H. Y., Kidd, S. E., Chen, S. C. ‐., Alastruey‐Izquierdo, A., Dao, A., Bongomin, F., Chiller, T. M., Wahyuningsih, R., Forastiero, A., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae040 · Cited by 59
Self-citationFluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008–2018
Won, E. J., Choi, M. J., Kim, M., Yong, D., Lee, W. G., Uh, Y., Kim, T. S., Byeon, S. A., Lee, S. Y., Kim, S. H., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2703.203482 · Cited by 59
Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study
Keighley, C., Chen, S. C. A., Marriott, D. J. E., Pope, A. L., Chapman, B., Kennedy, K., Bak, N., Underwood, N., Wilson, H. L., McDonald, K., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4065-5 · Cited by 54
Self-citationDeciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 59
Mamali, V., Siopi, M., Charpantidis, S., Samonis, G., Tsakris, A., Vrioni, G., & on behalf of the Candi-Candi Network (2022) · Journal of Fungi · doi:10.3390/jof8020116 · Cited by 57
Stavrou, A. A., Lackner, M., Lass‐Flörl, C., & Boekhout, T. (2019) · FEMS Yeast Research · doi:10.1093/femsyr/foz037 · Cited by 57
Asogan, M., Kim, H. Y., Kidd, S. E., Alastruey‐Izquierdo, A., Govender, N. P., Dao, A., Shin, J.-H., Heim, J., Ford, N. P., Gigante, V., et al. (2023) · Medical Mycology · doi:10.1093/mmy/myad131 · Cited by 53
Self-citationBiswas, C., Marcelino, V. R., Van Hal, S., Halliday, C., Martinez, E., Wang, Q., Kidd, S., Kennedy, K., Marriott, D., Morrissey, C. O., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02946 · Cited by 49
Self-citationA prospective, multi-center study of Candida bloodstream infections in Chile
Santolaya, M. E., Thompson, L., Dona Benadof, F., Tapia, C. V., Legarraga, P., Cortés, C. P., Rabello, M., Valenzuela, R., Rojas, P., Ricardo Rabagliati, B., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212924 · Cited by 56
Fuller, J., Dingle, T. C., Bull, A., Shokoples, S., Laverdière, M., Baxter, M. R., Adam, H. J., Karlowsky, J. A., Zhanel, G. G., Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD, et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz287 · Cited by 52
Rivero-Menéndez, O., Navarro-Rodríguez, P., Bernal‐Martínez, L., Martin-Cano, G., Lopez-Perez, L., Sánchez‐Romero, I., Pérez‐Ayala, A., Capilla, J., Zaragoza, Ó., & Alastruey‐Izquierdo, A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01585 · Cited by 47
Ko, J., Jung, D. S., Lee, J. Y., Kim, H. A., Ryu, S. Y., Jung, S., Joo, E., Cheon, S., Ys, K., Kim, S., et al. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.05.017 · Cited by 46
Xu, Z., Green, B., Benoit, N., Schatz, M., Wheelan, S., & Cormack, B. (2020) · Molecular Microbiology · doi:10.1111/mmi.14488 · Cited by 48
Song, Y., Chen, X., Yan, Y., Wan, Z., Liu, W., & Li, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01401 · Cited by 46
Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance
Gioia, F., Gómez‐López, A., Alvarez, M. E., de la Pedrosa, E. G., Martín‐Dávila, P., Cuenca‐Estrella, M., Moreno, S., & Fortün, J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.019 · Cited by 47
Kim, E. J., Lee, E., Kwak, Y. G., Yoo, H. M., Choi, J. Y., Kim, S. R., Shin, M. J., Yoo, S.-Y., Cho, N.-H., & Choi, Y. H. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.606976 · Cited by 47
Risk factors for candidaemia: A prospective multi‐centre case‐control study
Keighley, C., Pope, A., Marriott, D. J. E., Chapman, B., Bak, N., Daveson, K., Hajkowicz, K. M., Halliday, C. L., Kennedy, K., Kidd, S. E., et al. (2020) · Mycoses · doi:10.1111/myc.13211 · Cited by 48
Self-citationArastehfar, A., Daneshnia, F., Salehi, M., Yaşar, M., Hoşbul, T., Ilkit, M., Pan, W., Hagen, F., Arslan, N., Türk‐Dağı, H., et al. (2020) · Mycoses · doi:10.1111/myc.13104 · Cited by 42
Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan
Khalifa, H. O., Arai, T., Majima, H., Watanabe, A., & Kamei, K. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00783-20 · Cited by 42
Franconi, I., & Lupetti, A. (2023) · Journal of Fungi · doi:10.3390/jof9121188 · Cited by 46
Khan, Z., Ahmad, S., Mokaddas, E., Meis, J. F., Joseph, L., Abdullah, A., & Vayalil, S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01926-17 · Cited by 42
Identification of Cryptic Species of Four Candida Complexes in a Culture Collection
Fontecha, G. A., Montes, K., Ortíz, B., Galindo, C., & Braham, S. (2019) · Journal of Fungi · doi:10.3390/jof5040117 · Cited by 44
Antifungal stewardship: developments in the field
Urbancic, K. F., Thursky, K., Kong, D. C. M., Johnson, P. D. R., & Slavin, M. A. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000497 · Cited by 41
Self-citationMcTaggart, L. R., Cabrera, A. L., Cronin, K. I., & Kus, J. V. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00402-20 · Cited by 39
de Oliveira, J. S., Pereira, V. S., Castelo‐Branco, D. D. S. C. M., Cordeiro, R. D. A., Sidrim, J. J. C., Brilhante, R. S. N., & Rocha, M. F. G. (2020) · Canadian Journal of Microbiology · doi:10.1139/cjm-2019-0531 · Cited by 39
Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey
Adam, K.-M., Osthoff, M., Lamoth, F., Conen, A., Erard, V., Boggian, K., Schreiber, P. W., Zimmerli, S., Bochud, P.-Y., Neofytos, D., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab471 · Cited by 37
Stavrou, A. A., Hansen, A. P., Lackner, M., Lass‐Flörl, C., & Boekhout, T. (2020) · Medical Mycology · doi:10.1093/mmy/myaa005 · Cited by 38
Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016–2018)
Arastehfar, A. A., Yazdanpanah, S., Bakhtiari, M., Fang, W., Pan, W., Mahmoudi, S., Pakshir, K., Daneshnia, F., Boekhout, T., İlkit, M., et al. (2020) · Medical Mycology · doi:10.1093/mmy/myaa059 · Cited by 40
Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition
Rodrigues, C. F., Rodrigues, M. E., & Henriques, M. (2018) · Biofouling · doi:10.1080/08927014.2018.1472244 · Cited by 35
Kord, M., Salehi, M., Khodavaisy, S., Hashemi, S. J., Ghazvini, R. D., Rezaei, S., Maleki, A., Elmimoghaddam, A., Alijani, N., Abdollahi, A., et al. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001189 · Cited by 36
Valotteau, C., Prystopiuk, V., Cormack, B. P., & Dufrêne, Y. F. (2019) · mSphere · doi:10.1128/msphere.00277-19 · Cited by 36
Antifungal Susceptibility Testing and Identification
Kidd, S. E., Crawford, L. C., & Halliday, C. L. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.004 · Cited by 32
Self-citationMete, B., Zerdali, E. Y., Aygün, G., Saltoğlu, N., Balkan, İ. İ., Karaali, R., Kaya, S. Y., Karaismailoglu, B., Kaya, A., Ürkmez, S., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03994-6 · Cited by 36
Epidemiology of fungaemia in Sweden: A nationwide retrospective observational survey
Klingspor, L., Ullberg, M., Rydberg, J., Kondori, N., Serrander, L., Swanberg, J., Nilsson, K., Bengtén, C. J., Johansson, M., Granlund, M., et al. (2018) · Mycoses · doi:10.1111/myc.12816 · Cited by 35
Yuan, S., Sun, Y., Xiao, X.-J., Long, Y., & He, H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.720926 · Cited by 33
Current and promising pharmacotherapeutic options for candidiasis
Scorzoni, L., Fuchs, B. B., Junqueira, J. C., & Mylonakis, E. E. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1873951 · Cited by 36
Yeoh, D. K., Moore, A. S., Kotecha, R. S., Bartlett, A. W., Ryan, A. L., Cann, M. P., McMullan, B. J., Thursky, K., Slavin, M. A., Blyth, C. C., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29275 · Cited by 30
Self-citationLin, S., Chen, R., Zhu, S., Wang, H., Wang, L., Zou, J., Yan, J., Zhang, X., Farmakiotis, D., Tan, X., et al. (2018) · Mycopathologia · doi:10.1007/s11046-018-0258-5 · Cited by 33
Kajihara, T., Yahara, K., Nagi, M., Kitamura, N., Hirabayashi, A., Hosaka, Y., Abe, M., Miyazaki, Y., & Sugai, M. (2022) · Medical Mycology · doi:10.1093/mmy/myac071 · Cited by 29
Lausch, K. R., Søgaard, M., Rosenvinge, F. S., Johansen, H. K., Boysen, T., Røder, B. L., Mortensen, K. L., Nielsen, L. B., Lemming, L. E., Olesen, B. R. S., et al. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.08.010 · Cited by 30
Cell wall protein variation, break‐induced replication, and subtelomere dynamics in Candida glabrata
Xu, Z., Green, B., Benoit, N., Sobel, J. D., Schatz, M. C., Wheelan, S., & Cormack, B. P. (2021) · Molecular Microbiology · doi:10.1111/mmi.14707 · Cited by 29
Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital
Battistolo, J., Glampedakis, E., Damonti, L., Poissy, J., Grandbastien, B., Kalbermatter, L., Pagani, J., Eggimann, P., Bochud, P., Calandra, T., et al. (2021) · Mycoses · doi:10.1111/myc.13376 · Cited by 29
Thiyahuddin, N. M., Lamping, E., Rich, A. M., & Cannon, R. D. (2019) · Journal of Fungi · doi:10.3390/jof5020030 · Cited by 35
Silva, L. N., de Mello, T. P., Ramos, L. S., Branquinha, M. H., & dos Santos, A. L. S. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191025152412 · Cited by 29
Candidemia in Children: A 16-year Longitudinal Epidemiologic Study
Silvester, E. J., Watanabe, M., Pittet, L. F., Boast, A., Bryant, P. A., Haeusler, G. M., Daley, A. J., Curtis, N. C., & Gwee, A. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003082 · Cited by 29
Carrizo, S. L., Zampini, I. C., Sayago, J. E., Simirgiotis, M. J., Bórquez, J., Cuello, A. S., & Isla, M. I. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112553 · Cited by 26
Keighley, C., Gall, M. L., van Hal, S. J., Halliday, C. L., Chai, L. Y. A., Chew, K. L., Biswas, C., Slavin, M. A., Meyer, W., Sintchenko, V., et al. (2022) · Journal of Fungi · doi:10.3390/jof8090896 · Cited by 25
Self-citationEvolution of fungemia in an Italian region
Prigitano, A., Cavanna, C., Passera, M., Gelmi, M. L., Sala, E., Ossi, C. M., Grancini, A., Calabrò, M., Bramati, S., Tejada, M., et al. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.100906 · Cited by 24
Poissy, J., Rouzé, A., Cornu, M., Nseir, S., & Sendid, B. (2022) · Journal of Fungi · doi:10.3390/jof8090946 · Cited by 25
Candida glabrata: A Tale of Stealth and Endurance
Askari, F., & Kaur, R. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00477 · Cited by 23
Kontoyiannis, D. P., Bassetti, M., Nucci, M., Capparella, M. R., Yan, J. L., Aram, J. A., & Hogan, P. A. (2017) · Mycoses · doi:10.1111/myc.12641 · Cited by 22
Pham, L. T. T., Pharkjaksu, S., Chongtrakool, P., Suwannakarn, K., & Ngamskulrungroj, P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01194 · Cited by 23
Yeoh, S. F., Lee, T. J., Chew, K. L., Lin, S., Yeo, D., & Setia, S. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s165676 · Cited by 20
Hohmann, F. B., Chaves, R. C. D. F., Olivato, G. B., de Souza, G. M., Galindo, V. B., Silva, M., Martino, M. D. V., de Menezes, F. G., & Corrêa, T. D. (2023) · Journal of International Medical Research · doi:10.1177/03000605221131122 · Cited by 23
A Narrative Review of Invasive Candidiasis in the Intensive Care Unit
Noppè, E., Eloff, J. R. P., Keane, S., & Martín‐Loeches, I. (2024) · Therapeutic Advances in Pulmonary and Critical Care Medicine · doi:10.1177/29768675241304684 · Cited by 21
Alobaid, K., Asadzadeh, M., Ahmad, S., & Khan, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182292 · Cited by 21
Xiao, G., Liao, W., Zhang, Y., Luo, X., Zhang, C., Li, G., Yang, Y., & Xu, Y. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05291-1 · Cited by 22
Ding, L., Li, T., Bai, C., Zhang, Q., Li, Z., & Li, X. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05780-x · Cited by 20
Favarello, L. M., Nucci, M., Queiroz‐Telles, F., Guimarães, T., Salles, M. J. C., Sukiennik, T., da Matta, D. A., Melo, A. S. D. A., & Colombo, A. L. (2021) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2021.03.018 · Cited by 19
Lotfali, E., Fattahi, A., Sayyahfar, S., Ghasemi, R., Rabiei, M. M., Fathi, M., Vakili, K. G., Deravi, N., Soheili, A., Toreyhi, H., et al. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0235 · Cited by 23
Bretagne, S., Desnos‐Ollivier, M., Sitbon, K., Lortholary, O., Che, D., Dromer, F., & YEASTS, P. O. T. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.641965 · Cited by 19
Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality
Keighley, C., Pope, A. L., Marriott, D., Chen, S. C. ‐., Slavin, M. A., Australia and New Zealand Mycoses Interest Group, Arthur, I. H., Baird, R., Bak, N., Blyth, C. C., et al. (2023) · Medical Mycology · doi:10.1093/mmy/myad028 · Cited by 19
Self-citationBilal, H., Zhang, D., Shafiq, M., Khan, M. N., Chen, C., Khan, S., Wang, Q., Cai, L., Islam, R., Hu, H., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00708-23 · Cited by 24
The Catestatin-Derived Peptides Are New Actors to Fight the Development of Oral Candidosis
Mancino, D., Kharouf, N., Scavello, F., Hellé, S., Salloum-Yared, F., Mutschler, A., Mathieu, É., Lavall�e, P., Metz‐Boutigue, M., & Haïkel, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042066 · Cited by 18
Metadata
- Authors
- Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., Bak, N., Heath, C. H., Kennedy, K., Morrissey, C. O., Sorrell, T. C., van Hal, S., Keighley, C., Goeman, E., Underwood, N., Hajkowicz, K., Hofmeyr, A., Leung, M., Macesic, N., Botes, J., Blyth, C., Cooley, L., George, C. R., Kalukottege, P., Kesson, A., McMullan, B., Baird, R., Robson, J., Korman, T. M., Pendle, S., Weeks, K., & Chen, S.
- Affiliations
- The University of Sydney (AU)
- Peter MacCallum Cancer Centre (AU)
- St Vincent's Hospital Sydney (AU)
- Westmead Hospital (AU)
- South Australia Pathology (AU)
- Queen Elizabeth II Medical Centre (AU)
- Royal Adelaide Hospital (AU)
- The University of Western Australia (AU)
- Australian National University (AU)
- The Alfred Hospital (AU)
- Princess Alexandra Hospital (AU)
- The University of Queensland (AU)
- Liverpool Hospital (AU)
- Wollongong Hospital (AU)
- Royal Hobart Hospital (AU)
- Prince of Wales Hospital (AU)
- Sydney Children's Hospital (AU)
- Sullivan Nicolaides Pathology (AU)
- Monash Health (AU)
- Royal North Shore Hospital (AU)
- Corresponding author
- Chen, Sharon
- ORCID
- Slavin, Monica
- Halliday, Catriona
- Kidd, Sarah
- Arthur, Ian
- Heath, Christopher H.
- Kennedy, Karina
- Morrissey, C. Orla
- Sorrell, Tania C.
- Keighley, Caitlin
- Goeman, Emma
- Hajkowicz, Krispin
- Hofmeyr, Ann
- Leung, Michael
- Blyth, Christopher
- Cooley, Louise
- George, C. Robert
- McMullan, Brendan
- Robson, Jennifer
- Korman, Tony M.
- Pendle, Stella
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-11-08
- Volume
- 72
- Issue
- 4
- Pages
- dkw422
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2551720400
- Cited by
- 163
- References
- 22
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 13 · 2023: 14 · 2022: 13 · 2021: 25 · 2020: 28 · 2019: 32 · 2018: 19 · 2017: 11
- FWCI
- 19.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- Merck Sharp and Dohme, Australia
- Australasian Society for Infectious Diseases (ASID) Inc.
- Sydney Medical School Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, Candida albicans, Candida glabrata complex, Candida parapsilosis complex, Candida tropicalis, antifungal susceptibility, azole resistance, fluconazole resistance, voriconazole resistance, caspofungin resistance, echinocandin resistance, emerging fungal infections, incidence trends, Australia
- MeSH terms
- Caspofungin, Micafungin, Anidulafungin, Antifungal Agents, Australia, Azoles, Candida, Female, Humans, Male, Microbial Sensitivity Tests, Triazoles, Fluconazole, Incidence, Sequence Analysis, DNA, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Drug Resistance, Fungal, Candida tropicalis, Candida glabrata, Echinocandins, Lipopeptides, Candidemia, Voriconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.